Certain HTN Meds May Cut Deaths From Influenza, Pneumonia
Use of ACE-I/ARB vs nonuse linked to lower mortality for those hospitalized with flu, pneumonia.
Hypertension
Real-World Antihypertensive Prescribing Deviates From Guidelines, Study Says
The aim of the study was to analyze antihypertensive utilization patterns among patients with uncontrolled hypertension despite receiving therapy.
Tenapanor Under Review for Hyperphosphatemia in CKD
Tenapanor is a first-in-class oral medication that works by blocking the NHE3 transporter in the gastrointestinal tract.
Antihypertensive Drugs and Cancer Risk: Is There a Link?
Five antihypertensive drug classes were analyzed separately and were also compared to all other treatment groups, including placebo.
Empagliflozin Beneficial in Heart Failure With Reduced Ejection Fraction
In a trial, empagliflozin reduced the risks for heart failure hospitalization and renal outcomes in patients with heart failure with reduced ejection fraction.
Antihypertensive Meds and Depression Risk Examined
Depression rates down with nine antihypertensive agents, including enalapril, amlodipine, atenolol
FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use
Hydrochlorothiazide is indicated for the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives.
Spironolactone Use Associated With Reduced Prostate Cancer Risk
Men who had ever used spironolactone had decreased odds of prostate cancer compared with never-users, according to a study.
USPSTF Advises Hypertension Screening for All Adults
Blood pressure should be measured outside clinical setting to confirm diagnosis before treatment.
New Drug Product: Consensi
This slideshow shows drug information for Consensi. Click here for the complete Consensi monograph.
